Updates are available Correction dated 2022-01-17
Click to view Correction: https://doi.org/10.1038/s41391-021-00401-9
Updates are available Correction dated 2022-07-15
Click to view Correction: https://doi.org/10.1038/s41391-022-00578-7
-
Authors
Tagawa, Scott T. http://orcid.org/0000-0003-2777-8587
Ramaswamy, Krishnan http://orcid.org/0000-0003-0890-0268
Huang, Ahong
Mardekian, Jack
Schultz, Neil M.
Wang, Li
Sandin, Rickard
Lechpammer, Stanislav
George, Daniel J.
-
Funding
Funding for this research was provided by:
Pfizer
Astellas Pharma US
- License Information
-
More Information
Article History
Received: 15 July 2020
Revised: 7 December 2020
Accepted: 14 January 2021
First Online: 21 February 2021
Change Date: 15 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41391-022-00578-7
Change Date: 17 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41391-021-00401-9
Compliance with ethical standards
:
: The authors declare the following competing interests: Scott Tagawa has received personal honoraria and institutional research funding from Pfizer, Astellas, and Janssen. Krishnan Ramaswamy, Stanislav Lechpammer, Jack Mardekian, and Rickard Sandin are employees of Pfizer Inc., and own stock or stock options. Neil M. Schultz is an employee of Astellas Pharma Inc. and owns stock or stock options. Ahong Huang and Li Wang were former employees of STATinMED; STATinMED received compensation from the sponsors for the overall conduct of the study and development of this manuscript. Daniel J George has served as a consultant for Astellas, Janssen Pharmaceuticals, and Pfizer; has served on an advisory board for Astellas, has served on an Independent Monitoring Committee for Janssen Pharmaceuticals; has received an honorarium from Pfizer; and has received research support from Astellas, Janssen Pharmaceuticals, and Pfizer.
